# Menarini Group completes acquisition of Stemline Therapeutics

Menarini Group completed the acquisition of Stemline Therapeutics, a US-based biopharmaceutical company.

- Type: Acquisition
- Announced: 2020-06-10
- Where: United States
- Status: completed
- Products: biopharmaceuticals
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Menarini](https://endata.com/companies/47710.md) (acquirer)
- [Stemline Therapeutics](https://endata.com/companies/47792.md) (target)

## Sources

- [menarini.com](https://www.menarini.com/en-us/news/news-detail/menarini-group-completes-a-solid-year-of-operating-performance.html), 2020-06-10: "Completion of Stemline acquisition, a US based biopharmaceutical company, marks Menarin"
- [prnewswire.com](https://www.prnewswire.com/in/news-releases/menarini-group-completes-a-solid-year-of-operating-performance-861502208.html), 2020-06-10: "The acquisition of Stemline, a New York-based US biopharmaceutical company, which we have just completed is a key move in line with our strategy providing us an excellent foundation to tap into the world's largest pharmaceutical market"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.